iifl-logo

Panacea Biotec Ltd Quarterly Results

408.15
(1.25%)
Aug 22, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Financials

Particulars (Rupees in Crores.)Jun-2025Mar-2025Dec-2024Sept-2024Jun-2024

Gross Sales

166.7

132.53

163.49

147.35

115.72

Excise Duty

0

0

0

0

0

Net Sales

166.7

132.53

163.49

147.35

115.72

Other Operating Income

0

0

0

0

0

Other Income

16.99

36.3

6.39

7.42

6.54

Total Income

183.69

168.83

169.88

154.77

122.26

Total Expenditure

167.88

159.41

155.53

140.35

129.71

PBIDT

15.81

9.42

14.35

14.42

-7.45

Interest

0.86

1.04

0.99

0.98

0.87

PBDT

14.95

8.38

13.36

13.44

-8.32

Depreciation

8.39

8.42

8.98

8.68

8.73

Minority Interest Before NP

0

0

0

0

0

Tax

0

0.01

0

0

0

Deferred Tax

2.6

1.94

-0.06

0.05

-1.17

Reported Profit After Tax

3.96

-1.99

4.44

4.71

-15.88

Minority Interest After NP

-0.09

-0.1

-0.08

-0.09

-0.08

Net Profit after Minority Interest

4.05

-1.89

4.52

4.8

-15.8

Extra-ordinary Items

8.72

25.76

2.77

2.74

2.74

Adjusted Profit After Extra-ordinary item

-4.67

-27.65

1.75

2.06

-18.54

EPS (Unit Curr.)

0.66

-0.31

0.74

0.77

-2.59

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

6.13

6.13

6.13

6.13

6.13

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

9.48

7.1

8.77

9.78

-6.43

PBDTM(%)

8.96

6.32

8.17

9.12

-7.18

PATM(%)

2.37

-1.5

2.71

3.19

-13.72

Panacea Biotec: Related NEWS

Panacea Biotec Wins ₹127 Crore UNICEF Deal to Supply Polio Vaccines
27 Dec 2024|05:23 PM

Such a contract symbolizes Panacea Biotec's continued commitment toward global health by contributing its share of the fight against polio, a deadly disease prevalent in many pockets of the world.

Read More
Panacea Biotec Shares Gain Amid Karnataka's Dengue Epidemic Declaration
4 Sep 2024|09:31 AM

Panacea Biotec's stock has seen a 37% gain over the past six months. Panacea Biotec's stock has gained a total of 76% in the last one year.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.